黃夾次苷
|
|
|
- CAS號:
- 1182-87-2
- 英文名:
- PERUVOSIDE
- 英文別名:
- Enordin;encordin;Pervoside;peruvosid;PERUVOSIDE;(22)-enolide;PERUVOSIDE(RG);Peruvoside (90%);PERUVOSIDE USP/EP/BP;cannogeninthevetoside
- 中文名:
- 黃夾次苷
- 中文別名:
- 夾次苷;黃夾次苷;血糖皂甙;黃夾次苷甲;黃夾次甙甲;化合物 PERUVOSIDE
- CBNumber:
- CB0266619
- 分子式:
- C30H44O9
- 分子量:
- 548.66
- MOL File:
- 1182-87-2.mol
|
|
|
黃夾次苷化學性質
-
熔點:
-
161-164°C
-
|
-
比旋光度:
-
D22 -71.7° (c = 1.54 in methanol)
-
|
-
沸點:
-
540.83°C (rough estimate)
-
|
-
密度:
-
1.1277 (rough estimate)
-
|
-
折射率:
-
1.5500 (estimate)
-
|
-
儲存條件:
-
2-8°C
-
|
-
溶解度:
-
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
-
|
-
酸度系數(shù)(pKa):
-
12.92±0.70(Predicted)
-
|
-
形態(tài):
-
powder
-
|
-
顏色:
-
light yellow
-
|
黃夾次苷性質、用途與生產工藝
黃夾次苷 是一種有效的 Src，PI3K，JNK ，STAT，和 EGFR的抑制劑。Peruvoside 誘導細胞凋亡 (apoptosis) 和自噬 (autophagy)，在乳腺癌、肺癌、肝癌和白血病中具有廣譜的抗腫瘤活性。Peruvoside 對正義 RNA 病毒具有廣譜、強效的抗病毒活性。
Peruvoside 增加 Gefitinib (HY-50895) 耐藥腫瘤細胞 (A549，PC9/gef和H1975) 的敏感性。。
黃夾次苷
上下游產品信息
上游原料
下游產品
黃夾次苷
生產廠家
全球有 65家供應商
黃夾次苷國內生產廠家
1182-87-2, 黃夾次苷 相關搜索:
- 抑制劑
- 植物提取物
- 中草藥成分
- C30H44O9
- 化合物 PERUVOSIDE
- 血糖皂甙
- 黃夾次苷甲
- 黃夾次苷
- 黃夾次甙甲
- 夾次苷
- 1182-87-2
- Card-20(22)-enolide,3-[(6-deoxy-3-O-methyl-a-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3b,5b)-
- Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3β,5β)-
- (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
- PERUVOSIDE USP/EP/BP
- [3BETA,5BETA]-3-[6-DEOXY-3-O-METHYL-ALPHA-L-GLUCOPYRANOSYL)OXYL]-14-HYDROXY-19-OXOCARD-20[22]-ENOLIDE
- CANNOGENNIN-ALPHA-L-THEVETOSIDE
- peruvosid
- encordin
- card-20(22)-enolide,3-((6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydr
- cannogeninthevetoside
- cannogeninalpha-l-thevetoside
- 3-((6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydroxy-19-oxo-card-20
- (3-beta,5-beta)-oxy-19-oxo
- PERUVOSIDE(RG)
- PERUVOSIDE FROM THEVETIA NERIIFOLIA
- (3beta,5beta)-3-[(6-deoxy-3-O-methyl-alpha-L\-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- Peruvoside (90%)
- (3β,5β)-3-[(6-Deoxy-3-O-Methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
- Pervoside
- Enordin
- Cannogenin α-L-thevetoside
- 3β-[(6-Deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-5β,14β-card-20(22)-enolide
- (3β,5β)-3-(6-Deoxy-3-O-methyl-α-L-glucopyranosyl]oxyl)-14-hydroxy-19-oxocard-20(22)-enolide
- (22)-enolide
- PERUVOSIDE